The market continues to shrink and adjust, raising concerns about a retreat in the Siasun Robot&Automation Sector. Can the deep-sea Technology Concept hold the flag and launch a counterattack?
Track the entire lifecycle of the main Sector.
The founder sold the controlling stake at a 30% premium. Will Shaanxi Kanghui Pharmaceutical still sell medications in the future? | Quick read of the announcement
① Kanghui Holdings transferred 22% of its shares in Shaanxi Kanghui Pharmaceutical at 24.70 yuan/share, reflecting a premium of 31.24% compared to the price before the suspension. ② The business scope of the transferee, Yuehe Zhichuang, does not include any mention related to pharmaceuticals.
After two trading limit increases, Shaanxi Kanghui Pharmaceutical officially announced plans for a change in control, refuting rumors of a shell acquisition by Hengchang Pharmaceutical | Quick announcement summary.
① Due to the controlling shareholder planning a share transfer, Shaanxi Kanghui Pharmaceutical Stocks have been suspended from trading since the 19th. ② Shaanxi Kanghui Pharmaceutical stated that, aside from a small collaboration with Hengchang Pharmaceutical on a Business level, there is no related cooperation in terms of backdoor listing.
Many individuals have been penalized and will be listed as *ST! Orient Group Incorporation is on the "brink of life and death" | Quick read announcement.
① Orient Group Incorporation received the "Notice of Administrative Penalty" from the Securities Regulatory Commission, and several people including the actual controller Sun Hongwei were penalized; ② The company's Stocks were suspended from trading on March 17, and resumed trading on March 18 with a delisting risk warning.
Shanghai Xuerong Bio-Technology changes ownership, new actual controller sets a "hundred billion Market Cap" flag | Quick read announcement.
① The control of Shanghai Xuerong Bio-Technology has changed, with chairman Yang Yongping relinquishing the position of the company's controlling Shareholder and actual controller. ② Jiang Zhi, an entrepreneur from the Online Games industry, will become the new actual controller. He stated that he hopes to build Shanghai Xuerong Bio-Technology into a publicly traded company with a revenue of 10 billion and a Market Cap of 100 billion in the next 3 to 5 years.
The Chairman is under investigation, Wanchen Group: the matters involved are unrelated to the company's Operation | Brief announcement.
① Wancheng Group announces that Chairman Wang Jiankun has been placed under detention and is under investigation; the matters involved are unrelated to the company, and so far the company has not been asked to assist in the investigation. ② Reviewing Wang Jiankun's tenure, during his time, he promoted the transformation of Wancheng Group from edible mushroom cultivation to wholesale snack business.